Hutchison China MediTech
www.chi-med.com TICKER: HCM EXCHANGE: LLATEST REPORTS
Full Steam Ahead
Published: Aug 03 2012
Hutchison China MediTech (Chi-Med) is the holding company of a healthcare group based primarily in China which was listed on AIM in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.
Chi-Med is majority owned (72%) by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.
Chi-Med has two main Operating divisions: the China Healthcare division, which sells OTC drugs, prescription drugs and health food products in China, and the Drug R&D division, which focuses principally on developing drugs for the Chinese oncology market.
Over the medium term we expect further positive news of strategic partnerships for more of its drug candidates, which should result in further upside performance in the shares.
